Non patient-specific sterile compounded pharmaceutical products for patients in the NIH CC on an as called in basis.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N90025D00001
- Awardee
-
Quva Pharma, Inc. UEI MUABDCZXMLG4
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Notice of Intent to Sole Source; Monument Medical Special Notice · 25000116 · Posted Oct 25, 2024
- Last date to order 100% complete
- IDV ceiling
- $250,000.00
- Maximum order
- $250,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Institutes of Health (NIH) Clinical Center has awarded a single-award, indefinite delivery contract to Quva Pharma, Inc. to provide non-patient-specific sterile compounded pharmaceutical products for patients at the NIH Clinical Center on an as-needed basis. The contract has a ceiling value of $250,000 and a period of performance ending on September 30, 2025.
Quva Pharma, a specialized pharmaceutical company that operates as a 503B outsourcing facility, will supply sterile intravenous preparations, including patient-controlled analgesia systems (PCACs) and epidurals, to support the NIH Clinical Center's pain management initiatives and clinical research. This contract award is the result of a sole-source acquisition conducted under simplified acquisition procedures, as the government has determined Quva Pharma to be the only reasonably available source for these specialized compounded pharmaceutical products. The contract does not include any set-aside designations, indicating Quva Pharma competed for this requirement in full and open competition.
Quick answers
Who was awarded contract 75N90025D00001?
75N90025D00001 was awarded to Quva Pharma, Inc. by NIH Clinical Center (National Institutes of Health) on December 4, 2024.
How much is contract 75N90025D00001 worth?
75N90025D00001's own ceiling is $250,000. A single order can be worth up to $250,000.
Who can order from contract 75N90025D00001?
75N90025D00001 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N90025D00001 competed?
The extent of competition for 75N90025D00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV